237 related articles for article (PubMed ID: 8137265)
21. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
Fichtinger-Schepman AM; Vendrik CP; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; Claessen AM; van der Velde-Visser SD; de Groot G; Wubs KL; Steerenberg PA
Cancer Res; 1989 Jun; 49(11):2862-7. PubMed ID: 2720647
[TBL] [Abstract][Full Text] [Related]
22. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
[TBL] [Abstract][Full Text] [Related]
23. Automated monitoring of apoptosis in suspension cell cultures.
Kravtsov VD; Fabian I
Lab Invest; 1996 Feb; 74(2):557-70. PubMed ID: 8780173
[TBL] [Abstract][Full Text] [Related]
24. Protection by ascorbate against apoptosis of thymocytes: implications of ascorbate-induced nonlethal oxidative stress and poly(ADP-ribosyl)ation.
Maellaro E; Bello BD; Comporti M
Exp Cell Res; 1996 Jul; 226(1):105-13. PubMed ID: 8660945
[TBL] [Abstract][Full Text] [Related]
25. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
[TBL] [Abstract][Full Text] [Related]
26. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
27. Thymic model for examining BRCA2 expression and function.
Flores KG; McAllister KA; Greer PK; Wiseman RW; Hale LP
Mol Carcinog; 2002 Nov; 35(3):103-9. PubMed ID: 12410562
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of dexamethasone-induced apoptosis in rat thymocytes by herbimycin A.
Lee E; Miura M; Yoshinari M; Iwai H; Kariya K
Biochem Biophys Res Commun; 1994 Jul; 202(1):128-34. PubMed ID: 8037703
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1998; 12(1):123-33. PubMed ID: 9575434
[TBL] [Abstract][Full Text] [Related]
30. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
McDonald ES; Randon KR; Knight A; Windebank AJ
Neurobiol Dis; 2005 Mar; 18(2):305-13. PubMed ID: 15686959
[TBL] [Abstract][Full Text] [Related]
33. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
34. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
35. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implications for gene therapy.
Skladanowski A; Larsen AK
Cancer Res; 1997 Mar; 57(5):818-23. PubMed ID: 9041178
[TBL] [Abstract][Full Text] [Related]
36. Thymic nurse cells as the site of thymocyte apoptosis and apoptotic cell clearance in the thymus of cyclophosphamide-treated mice.
Hiramine C; Nakagawa T; Miyauchi A; Hojo K
Lab Invest; 1996 Aug; 75(2):185-201. PubMed ID: 8765319
[TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline stimulates drug-induced apoptosis in leukemic cells.
Rauko P; Sedlák J; Duraj J; Szekeres MF; Novotný L
Neoplasma; 1998; 45(5):296-300. PubMed ID: 9921918
[TBL] [Abstract][Full Text] [Related]
38. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Catchpoole DR; Stewart BW
Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
[TBL] [Abstract][Full Text] [Related]
39. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
40. Identification of a transitional preapoptotic population of thymocytes.
Cohen GM; Sun XM; Snowden RT; Ormerod MG; Dinsdale D
J Immunol; 1993 Jul; 151(2):566-74. PubMed ID: 8335900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
